This study will assess the safety and efficacy of secukinumab compared to placebo in patients that have moderate to severe, chronic, plaque-type psoriasis.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01365455?cond=%22Arthritis%22&lup_s=07/14/2011&lup_d=30
